Geographic and Racial Variation in Oral Anticoagulant Treatment Among Commercially Insured Patients With Non-Valvular Atrial Fibrillation in the United States

被引：0
|
作者：
Atwater, Brett D.
Singh, Risho
Parmar, Shashi
Ogbonnaya, Augustina
Kang, Amiee
Russ, Cristina
Cheng, Dong
Hagan, Melissa
Deeba, Serina
Hines, Dionne M.
Atreja, Nipun
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Atrial fibrillation; Anticoagulants; Race;
D O I：
10.1161/circ.148.suppl_1.14004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14004
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Geographic and Racial Variation in Oral Anticoagulant (OAC) Treatment Among Commercially Insured Patients with Non-valvular Atrial Fibrillation (NVAF) in the United States
    Atwater, Brett D.
    Singh, Risho
    Parmar, Shashi
    Ogbonnaya, Augustina
    Kang, Amiee
    Atreja, Nipun
    Russ, Cristina
    Cheng, Dong
    Hagan, Melissa
    Deeba, Serina
    Hines, Dionne M.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025,
  • [2] Racial Disparities and Geographic Variation in Anticoagulant Treatment Among Medicare Beneficiaries With Non-Valvular Atrial Fibrillation in the United States
    Kang, Amiee
    Noxon, Virginia
    Atreja, Nipun
    Hines, Dionne
    Jiang, Jenny
    Ferri, Mauricio
    CIRCULATION, 2022, 146
  • [3] Racial differences and geographic variations in oral anticoagulation treatment among Medicare patients with non-valvular atrial fibrillation
    Jackson, Larry R.
    Kang, Amiee
    Noxon, Virginia
    Atreja, Nipun
    Hines, Dionne M.
    Hagan, Melissa
    Jiang, Jenny
    Atwater, Brett D.
    PLOS ONE, 2024, 19 (12):
  • [4] Persistence to Oral Anticoagulation Treatment in Non-valvular Atrial Fibrillation Patients in the United States
    Dhamane, Amol
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Keshishian, Allison
    CIRCULATION, 2020, 142
  • [5] Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
    Xiong, Qinmei
    Shantsila, Alena
    Li, Juxiang
    Hong, Kui
    Lip, Gregory Y. H.
    ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (01) : 216 - 218
  • [6] Treatment and Persistence With Oral Anticoagulants Among Newly Diagnosed Patients With Non-Valvular Atrial Fibrillation in a Commercially Insured and Medicare Advantage Population
    Jain, Rahul
    Franchino-Elder, Jessica
    Fu, An-Chen
    Wang, Cheng
    Sander, Stephen
    Tan, Hiangkiat
    Kraft, Elizabeth
    Willey, Vincent
    CIRCULATION, 2016, 134
  • [7] PRICE ELASTICITY OF DEMAND FOR NEW ORAL ANTICOAGULANT AGENTS AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Liu, S.
    Jackson, J.
    Khalaf, K.
    Meyer, K. L.
    Brown, D.
    VALUE IN HEALTH, 2016, 19 (03) : A49 - A49
  • [8] Variability in the benefit of the novel oral anticoagulant agents in patients with non-valvular atrial fibrillation
    Giuseppe Patti
    Ilaria Cavallari
    Internal and Emergency Medicine, 2015, 10 : 395 - 396
  • [9] Reasons for discontinuation of direct oral anticoagulant therapy in patients with non-valvular atrial fibrillation
    Renner, Elizabeth
    Mouland, Erin
    Saad, Samira
    Ha, Nghi
    Kim, Pauline
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 617 - 618
  • [10] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Mehmet Agirbasli
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 570 - 570
12345